ethinyl estradiol-norgestrel combination has been researched along with Compensatory Hyperinsulinemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, IK; Olatunji, LA; Seok, YM; Usman, TO | 1 |
Olaniyi, KS; Olatunji, LA | 1 |
2 other study(ies) available for ethinyl estradiol-norgestrel combination and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Activation of cardiac renin-angiotensin system and plasminogen activator inhibitor-1 gene expressions in oral contraceptive-induced cardiometabolic disorder.
Topics: Aldosterone; Animals; Ataxia Telangiectasia Mutated Proteins; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dyslipidemias; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Intolerance; Heart; Hyperinsulinism; Hypertension; Insulin Resistance; Metabolic Syndrome; Myocardium; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Random Allocation; Rats, Sprague-Dawley; Renin-Angiotensin System; Up-Regulation | 2017 |
Oral ethinylestradiol-levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats.
Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Fructose; Glucosephosphate Dehydrogenase; Glycogen; Hyperinsulinism; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Lipid Peroxidation; Liver; Protein Kinases; Rats; Rats, Wistar; Uric Acid | 2019 |